Ibuprofen/Oxycodone Hydrochloride

布洛芬/盐酸羟考酮

Report date: 2022/09/08 16:56:42

Base Information

Drug NameIbuprofen/Oxycodone Hydrochloride
Drug Alias Name盐酸羟考酮/布洛芬Oxycodone hydrochloride/ibuprofenibuprofen and oxycodone hydrochlorideoxycodone hydrochloride and ibuprofenOxycodone HCl and Ibuprofen +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsOpioid receptors agonists
TargetsOpioid receptorsCyclooxygenases
Therapy Area/IndicationsAcute PainPain
Global Approved IndicationsAcute Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/11/26
Country/TerritoryUnited StatesBrazilMainland China
CombinationsYes IbuprofenOxycodone Hydrochloride Hydrate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co LtdEurofarma Laboratorios SaJiangsu Nhwa Pharmaceutical Co Ltd +[4] 
Inactive CompaniesForest Laboratories Inc
Active IndicationsPain
Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A